Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP492150.RAVP4xWAjjLjKEe-bZkjWsPzmKdUkK0kW6hIO-B4Hrgzg130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492150.RAVP4xWAjjLjKEe-bZkjWsPzmKdUkK0kW6hIO-B4Hrgzg130_provenance.
• NP201162.RAuWT_3-vel2fJtvk9256MEPKq1E64r8v4hjnIKg1nKbs130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP201162.RAuWT_3-vel2fJtvk9256MEPKq1E64r8v4hjnIKg1nKbs130_provenance.
• NP462417.RACQBASMiHxbXkIXCzHnWlY8X_UqMxEV4dEcVddJ1X66Y130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP462417.RACQBASMiHxbXkIXCzHnWlY8X_UqMxEV4dEcVddJ1X66Y130_provenance.
• NP512368.RAa6IJZAjRC1O5HEpWrCdBZlxcpAClxFmxtivsP1bmhJI130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP512368.RAa6IJZAjRC1O5HEpWrCdBZlxcpAClxFmxtivsP1bmhJI130_provenance.
• NP613948.RAgTKH8v7gLWr4fk7e-f9qYI1y0emqgn6CD9NK3QFVvKU130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613948.RAgTKH8v7gLWr4fk7e-f9qYI1y0emqgn6CD9NK3QFVvKU130_provenance.
• NP482255.RAYDXra1CapJgRWMgvLPiCGYER_uWPOn41vrMTefuJNNc130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482255.RAYDXra1CapJgRWMgvLPiCGYER_uWPOn41vrMTefuJNNc130_provenance.
• NP690006.RA2TvA7SYyBYxHQyJg8lLVFSS1SGsofyseUcjzkzFNddc130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690006.RA2TvA7SYyBYxHQyJg8lLVFSS1SGsofyseUcjzkzFNddc130_provenance.
• NP753978.RAkQlbtRr31t1jvtuR4nOcvIWdiIstgkHlLsaMh9a6hgI130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP753978.RAkQlbtRr31t1jvtuR4nOcvIWdiIstgkHlLsaMh9a6hgI130_provenance.
• NP224365.RAMiPTNYNQiR_D3iFbQuXYrGmDJTeQwMKXygawT8MbeLk130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP224365.RAMiPTNYNQiR_D3iFbQuXYrGmDJTeQwMKXygawT8MbeLk130_provenance.
• NP319059.RAK1fXnVAKb5sC9tp6kuvcVLwZ4J5l6rO-HCbdbwIvjxQ130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP319059.RAK1fXnVAKb5sC9tp6kuvcVLwZ4J5l6rO-HCbdbwIvjxQ130_provenance.
• NP816646.RA_EJkbz6OAKmtlI6jpDAnC3AvqYSUfNVZVIX6MGrmhYI130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816646.RA_EJkbz6OAKmtlI6jpDAnC3AvqYSUfNVZVIX6MGrmhYI130_provenance.
• NP888524.RAzNbg6c9H1EUC2EnTJgr-4Koh0ytzUt0ohEE7F9sb008130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888524.RAzNbg6c9H1EUC2EnTJgr-4Koh0ytzUt0ohEE7F9sb008130_provenance.
• NP913587.RA9GMeE29mDQ63aO1-UZwJ5rOKVsnfcekDk9ucu-Ti2Zg130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913587.RA9GMeE29mDQ63aO1-UZwJ5rOKVsnfcekDk9ucu-Ti2Zg130_provenance.
• NP426919.RA8F25_mCidcXI9wVaqKoLLy_rFiST3OKu-XEloDGiSaI130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP426919.RA8F25_mCidcXI9wVaqKoLLy_rFiST3OKu-XEloDGiSaI130_provenance.
• NP1092028.RABfopa3hX_QXiXgtIM8Vaa1Q5LDZ3it7VXnHOJUALKk8130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092028.RABfopa3hX_QXiXgtIM8Vaa1Q5LDZ3it7VXnHOJUALKk8130_provenance.
• NP547851.RA96tVz50pEDa95vKdHnYW4FzrPyML1vJ2BpAC47rPV6M130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547851.RA96tVz50pEDa95vKdHnYW4FzrPyML1vJ2BpAC47rPV6M130_provenance.
• NP390144.RAS4StFDyZIfXn1JQUAXJT4IiNV5RJFsVgBjTEnoC5k4M130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390144.RAS4StFDyZIfXn1JQUAXJT4IiNV5RJFsVgBjTEnoC5k4M130_provenance.
• assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP943717.RAXvGaHRzvWmdzzzt3ZuUL-ge7GjR9ZT0FSkHL5Qr6wGY130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP943717.RAXvGaHRzvWmdzzzt3ZuUL-ge7GjR9ZT0FSkHL5Qr6wGY130_provenance.
• NP943789.RAdCliL4SC2fzUGVsMDlERNQCtrV1cLgjMf9smyeg5Z3A130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP943789.RAdCliL4SC2fzUGVsMDlERNQCtrV1cLgjMf9smyeg5Z3A130_provenance.
• NP808950.RAY2p6FSiBhrOUpwmAdCUUCLPf9UPC6SZqLKAJwbNsdac130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808950.RAY2p6FSiBhrOUpwmAdCUUCLPf9UPC6SZqLKAJwbNsdac130_provenance.
• NP1092026.RAyMFEgoA6cv9CiyaXf2HTnAJu2OEPyR3uUrBs2BQz568130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092026.RAyMFEgoA6cv9CiyaXf2HTnAJu2OEPyR3uUrBs2BQz568130_provenance.
• NP547934.RAOpgq3nWGYIK0ObOaXohh02waQ7s7T2miYnkkF6Daxgw130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547934.RAOpgq3nWGYIK0ObOaXohh02waQ7s7T2miYnkkF6Daxgw130_provenance.
• NP1092020.RAabaW-momDQX0sb5pR-vWt32FDC7vFEdtkd5BTUC0FL0130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092020.RAabaW-momDQX0sb5pR-vWt32FDC7vFEdtkd5BTUC0FL0130_provenance.
• NP1092024.RAeOXAPsaE-IcFKkaggWyJgjazlMu-osB9v0p1LpDE76w130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092024.RAeOXAPsaE-IcFKkaggWyJgjazlMu-osB9v0p1LpDE76w130_provenance.
• assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP974497.RAqyZz8XICc5R6HksdaDdqFgKYQgvMAiOoPAIa33QG7mc130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974497.RAqyZz8XICc5R6HksdaDdqFgKYQgvMAiOoPAIa33QG7mc130_provenance.
• assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP974428.RAP-MCq7Yy8U2DchC5ZFnXUGbJK73f_UnoLRk3vkTWeCE130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974428.RAP-MCq7Yy8U2DchC5ZFnXUGbJK73f_UnoLRk3vkTWeCE130_provenance.
• NP1092031.RAGq7PSo_7btlnMZBnQd81w6AD65xVccYJ3vp1JkALHrU130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092031.RAGq7PSo_7btlnMZBnQd81w6AD65xVccYJ3vp1JkALHrU130_provenance.
• NP390012.RArtoEUj5ore7IUC9z0o6K5nQbA_L5JVXL_lWr4gs2G5o130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390012.RArtoEUj5ore7IUC9z0o6K5nQbA_L5JVXL_lWr4gs2G5o130_provenance.
• NP808702.RAuq25QD4BHl4fxpIFECOtKE3u6LOG_kJu7dmXUEqKUSw130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808702.RAuq25QD4BHl4fxpIFECOtKE3u6LOG_kJu7dmXUEqKUSw130_provenance.
• NP1092021.RAvY7AQH0pGrdqleWvtqToKGmD6s1FUEe1Nfwd-gjKGeo130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092021.RAvY7AQH0pGrdqleWvtqToKGmD6s1FUEe1Nfwd-gjKGeo130_provenance.
• NP1092022.RAqrKQ4fpYN1Qey83orgw7eCgIR7dFOYC4RuE7ZXIpY_A130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092022.RAqrKQ4fpYN1Qey83orgw7eCgIR7dFOYC4RuE7ZXIpY_A130_provenance.
• NP1092025.RAh4Rx3WrWqwpe1_GFtrLYMY4zXtpCwS29Q_Zqczf5PUk130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092025.RAh4Rx3WrWqwpe1_GFtrLYMY4zXtpCwS29Q_Zqczf5PUk130_provenance.
• NP1092029.RAlrXJNiqjwqVeuWy7ShYfAyP9BLwpeimY4MGx6cCubfY130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092029.RAlrXJNiqjwqVeuWy7ShYfAyP9BLwpeimY4MGx6cCubfY130_provenance.
• NP1092030.RAjnAHlrOmWpI3to6-gAk7RBBveviFcRgFUOub9ClBh1Q130_assertion description "[Microinjection of PAR1 agonists, including Klk6 or PAR1-APs, into the dorsal column white matter of PAR1(+/+) but not PAR1(-/-) mice promoted vacuolating myelopathy and a loss of immunoreactivity for myelin basic protein (MBP) and CC-1(+) oligodendrocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092030.RAjnAHlrOmWpI3to6-gAk7RBBveviFcRgFUOub9ClBh1Q130_provenance.